What is the Clinical Trials and Cohort Studies Grants?

The Clinical Trials and Cohort Studies Grants is a grant opportunity to support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health. This grant opportunity is open to research
proposals for clinical trials and/or cohort studies of any size – that is, they may be large or small clinical trials or cohort studies.

 

Funding

The funding allocation for this grant opportunity is estimated to be up to $70 million. NHMRC’s Research Committee annually reviews and recommends indicative budget amounts to be awarded across individual funding schemes.

The amount of funding will be based on assessment of the requested budget. Applications must clearly justify the requested duration and budget and how this will support the proposed outcomes of the research. Peer Reviewers will consider this information and may reduce the duration and/or budget to ensure the research aims and objectives can be achieved while ensuring value with money.

 

Eligible Projects

The intended outcomes of the scheme are improvements in health and well-being, health care and practice or policy, as a result of:

  • High-quality clinical trials that provide reliable evidence of the effects of health-related interventions on health outcomes* (or appropriate surrogates). This means that:
    • the project must involve human participants
    • the participants are prospectively assigned to one or more interventions
    • the effects of the intervention(s) on the participants will be examined, and
    • the anticipated effects of the intervention will be a behavioural and/or health-related outcome.
  • High-quality cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes. This means that:
    • the project must involve human participants
    • the participants are prospectively followed over a defined period of time, and
    • the project aims to evaluate associations between one or more factors in the cohort with a behavioural and/or health-related outcome.
  • High quality retrospective cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes. This means that:
    • the project must involve human participants
    • the project will collect and examine retrospective data and may involve some elements of data linkage work, and
    • the project aims to evaluate associations between one or more factors in the cohort with a behavioural and/or health-related outcome.

 

Eligible Applicants

Applications will only be accepted from NHMRC-approved Administering Institutions. A list of NHMRC-approved Administering Institutions and NHMRC’s Administering Institution Policy are available on NHMRC’s website.

The maximum number of CIs allowed is ten (CIA-CIJ).

There are no limits to the number of applications a CI may make to the this grant opportunity and the number is also not affected by other NHMRC grants applied for or held by the CI.

 

Timing

Applications close 20 November 2020.

 

More Information